US5744347A
(en)
*
|
1987-01-16 |
1998-04-28 |
Ohio University Edison Biotechnology Institute |
Yolk sac stem cells and their uses
|
US5635386A
(en)
*
|
1989-06-15 |
1997-06-03 |
The Regents Of The University Of Michigan |
Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture
|
US5399493A
(en)
*
|
1989-06-15 |
1995-03-21 |
The Regents Of The University Of Michigan |
Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
|
US5763266A
(en)
*
|
1989-06-15 |
1998-06-09 |
The Regents Of The University Of Michigan |
Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells
|
US5605822A
(en)
*
|
1989-06-15 |
1997-02-25 |
The Regents Of The University Of Michigan |
Methods, compositions and devices for growing human hematopoietic cells
|
US5061620A
(en)
*
|
1990-03-30 |
1991-10-29 |
Systemix, Inc. |
Human hematopoietic stem cell
|
US5635387A
(en)
*
|
1990-04-23 |
1997-06-03 |
Cellpro, Inc. |
Methods and device for culturing human hematopoietic cells and their precursors
|
US5840580A
(en)
*
|
1990-05-01 |
1998-11-24 |
Becton Dickinson And Company |
Phenotypic characterization of the hematopoietic stem cell
|
US5622853A
(en)
*
|
1990-05-01 |
1997-04-22 |
Becton Dickinson And Company |
T lymphocyte precursor
|
US6631842B1
(en)
*
|
2000-06-07 |
2003-10-14 |
Metrologic Instruments, Inc. |
Method of and system for producing images of objects using planar laser illumination beams and image detection arrays
|
US5541072A
(en)
*
|
1994-04-18 |
1996-07-30 |
Immunivest Corporation |
Method for magnetic separation featuring magnetic particles in a multi-phase system
|
US6010696A
(en)
*
|
1990-11-16 |
2000-01-04 |
Osiris Therapeutics, Inc. |
Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells
|
US5348859A
(en)
*
|
1990-11-23 |
1994-09-20 |
Coulter Corporation |
Method and apparatus for obtaining an absolute white blood cell subset count and white blood cell multipart differential
|
US5340719A
(en)
*
|
1990-11-23 |
1994-08-23 |
Corporation Coulter |
Method and apparatus for optically screening microscopic cells
|
US5994088A
(en)
|
1991-03-08 |
1999-11-30 |
Board Of Trustees Of The University Of Illinois |
Methods and reagents for preparing and using immunological agents specific for P-glycoprotein
|
US5464753A
(en)
*
|
1991-03-08 |
1995-11-07 |
Univ Illinois |
Purification and manipulation of bone marrow and blood cells on the basis of P-glycoprotein expression
|
US5849686A
(en)
*
|
1991-03-11 |
1998-12-15 |
Creative Biomolecules, Inc. |
Morphogen-induced liver regeneration
|
US5795470A
(en)
*
|
1991-03-25 |
1998-08-18 |
Immunivest Corporation |
Magnetic separation apparatus
|
US5367057A
(en)
|
1991-04-02 |
1994-11-22 |
The Trustees Of Princeton University |
Tyrosine kinase receptor flk-2 and fragments thereof
|
US5185438A
(en)
*
|
1991-04-02 |
1993-02-09 |
The Trustees Of Princeton University |
Nucleic acids encoding hencatoporetic stem cell receptor flk-2
|
ATE169031T1
(de)
*
|
1991-04-05 |
1998-08-15 |
Univ Washington |
Zellrezeptor spezifische monoklonale antikörper gegen stammzell-faktor-rezeptor
|
EP0584184A4
(en)
|
1991-04-09 |
1995-12-27 |
Indiana University Foundation |
System and process for supporting hematopoietic cells
|
US5744361A
(en)
*
|
1991-04-09 |
1998-04-28 |
Indiana University |
Expansion of human hematopoietic progenitor cells in a liquid medium
|
US6069005A
(en)
|
1991-08-07 |
2000-05-30 |
Albert Einstein College Of Medicine Of Yeshwa University |
Hapatoblasts and method of isolating same
|
EP0597964A4
(de)
*
|
1991-08-07 |
1994-11-30 |
Einstein Coll Med |
Proliferation von vorläufern von hepatocyten.
|
NL9101680A
(nl)
*
|
1991-10-04 |
1993-05-03 |
Tno |
Werkwijze voor het genetisch modificeren van beenmergcellen van primaten, alsmede daarbij bruikbare cellen die recombinante retrovirale vectoren produceren.
|
DE69232682T2
(de)
*
|
1991-10-23 |
2003-03-13 |
Nexell Therapeutics Inc |
Verfahren zur selektiven vermehrung von cd34 positiven zellen
|
CA2122140A1
(en)
*
|
1991-10-23 |
1993-04-29 |
Dale R. Peterson |
Method for freezing engrafting cells
|
US6353150B1
(en)
*
|
1991-11-22 |
2002-03-05 |
Hsc Research And Development Limited Partnership |
Chimeric mammals with human hematopoietic cells
|
WO1993018136A1
(en)
*
|
1992-03-05 |
1993-09-16 |
Cytomed, Inc. |
Process for supporting hematopoietic progenitor cells
|
SG47041A1
(en)
*
|
1992-03-23 |
1998-03-20 |
Bender James G |
In vitro-derived human neutrophil precursor cells
|
US5888499A
(en)
*
|
1992-03-23 |
1999-03-30 |
Nexell Therapeutics Inc. |
Method for increasing neutrophil populations using in vitro-derived human neutrophil precursor cells
|
US5436151A
(en)
*
|
1992-04-03 |
1995-07-25 |
Regents Of The University Of Minnesota |
Method for culturing human hematopoietic stem cells in vitro
|
US5460964A
(en)
*
|
1992-04-03 |
1995-10-24 |
Regents Of The University Of Minnesota |
Method for culturing hematopoietic cells
|
IL106295A
(en)
*
|
1992-07-10 |
2001-03-19 |
Univ Pittsburgh |
Hematopoietic facilitaroy cells
|
CA2139877C
(en)
*
|
1992-07-10 |
2006-09-19 |
Suzanne T. Ildstad |
Hematopoietic facilitatory cells and their uses
|
US5693482A
(en)
*
|
1992-07-27 |
1997-12-02 |
California Institute Of Technology |
Neural chest stem cell assay
|
US5589376A
(en)
*
|
1992-07-27 |
1996-12-31 |
California Institute Of Technology |
Mammalian neural crest stem cells
|
NZ256154A
(en)
*
|
1992-07-27 |
1997-02-24 |
California Inst Of Techn |
Production of mammalian multipotent neural stem cells, antibodies
|
US5654183A
(en)
*
|
1992-07-27 |
1997-08-05 |
California Institute Of Technology |
Genetically engineered mammalian neural crest stem cells
|
US5849553A
(en)
*
|
1992-07-27 |
1998-12-15 |
California Institute Of Technology |
Mammalian multipotent neural stem cells
|
EP0652703A4
(de)
*
|
1992-07-28 |
1996-05-29 |
Steven Kessler |
Verfahren für die positive immunoselektion von stammzellen.
|
CA2080255A1
(en)
*
|
1992-07-31 |
1994-02-01 |
Connie J. Eaves |
Primitive hematopoietic stem cell preparations
|
WO1994005775A1
(en)
*
|
1992-09-03 |
1994-03-17 |
Systemix, Inc. |
High speed flow cytometric separation of viable mammalian cells
|
US5466572A
(en)
*
|
1992-09-03 |
1995-11-14 |
Systemix, Inc. |
High speed flow cytometric separation of viable cells
|
US5342776A
(en)
*
|
1992-09-04 |
1994-08-30 |
Bolnet Marie C N |
Avian hemopoietic progenitor cells
|
WO1994008039A1
(en)
*
|
1992-10-02 |
1994-04-14 |
Systemix, Inc. |
Method of enrichment for human hematopoietic stem cells using c-kit
|
US5766951A
(en)
*
|
1992-11-12 |
1998-06-16 |
Quality Biological, Inc. |
Serum-free medium supporting growth and proliferation of normal bone marrow cells
|
ATE150975T1
(de)
*
|
1992-11-13 |
1997-04-15 |
Univ Washington |
Peripheralisierung hämatopoietischer stammzellen
|
EP0669974A1
(de)
*
|
1992-11-16 |
1995-09-06 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Pluripotente ruhende Stammzellpopulationen
|
US5409710A
(en)
*
|
1993-04-20 |
1995-04-25 |
Endocon, Inc. |
Foam cell drug delivery
|
EP0697880B1
(de)
*
|
1993-05-03 |
2001-08-22 |
Genentech, Inc. |
Inhibierung von Leukozytenadhäsion
|
WO1994027622A1
(en)
*
|
1993-05-24 |
1994-12-08 |
The Johns Hopkins University |
Surrogate tolerogenesis for the development of tolerance to xenografts
|
NZ314644A
(en)
|
1993-05-24 |
2000-11-24 |
Immunex Corp |
Use of flt3-ligands as a growth stimulator of stem cells in the transplantation of tissue
|
US5554512A
(en)
*
|
1993-05-24 |
1996-09-10 |
Immunex Corporation |
Ligands for flt3 receptors
|
US5772994A
(en)
*
|
1993-05-28 |
1998-06-30 |
The University Of Pittsburgh |
Hematopoietic facilitatory cells and their uses
|
US6033906A
(en)
*
|
1993-07-26 |
2000-03-07 |
California Institute Of Technology |
Methods for differentiating neural stem cells to glial cells using neuregulins
|
JPH09502167A
(ja)
*
|
1993-07-29 |
1997-03-04 |
システミックス,インコーポレイテッド |
新規な幹細胞マーカー
|
CA2170357A1
(en)
*
|
1993-08-25 |
1995-03-02 |
David Digiusto |
Method for producing a highly enriched population of hematopoietic stem cells
|
CA2171112A1
(en)
*
|
1993-09-08 |
1995-03-16 |
Neil I. Goldstein |
Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations
|
EP0736169A4
(de)
*
|
1993-09-17 |
1998-06-10 |
Systemix Inc |
Verfahren zum erhalt einer mit stammzellen angereicherten zellpopulation und damit erhaltene zusammensetzungen
|
US5409813A
(en)
*
|
1993-09-30 |
1995-04-25 |
Systemix, Inc. |
Method for mammalian cell separation from a mixture of cell populations
|
US5599703A
(en)
*
|
1993-10-28 |
1997-02-04 |
The United States Of America As Represented By The Secretary Of The Navy |
In vitro amplification/expansion of CD34+ stem and progenitor cells
|
US6190655B1
(en)
|
1993-12-03 |
2001-02-20 |
Immunex Corporation |
Methods of using Flt-3 ligand for exogenous gene transfer
|
EP0740553B1
(de)
*
|
1994-01-05 |
2004-09-15 |
University Of Pittsburgh |
Monoklonale antikörper gegen antigene, die durch hämatopoietische helferzellen exprimiert werden
|
US6001654A
(en)
*
|
1994-01-28 |
1999-12-14 |
California Institute Of Technology |
Methods for differentiating neural stem cells to neurons or smooth muscle cells using TGT-β super family growth factors
|
US6448077B1
(en)
*
|
1994-02-10 |
2002-09-10 |
Imclone Systems, Inc. |
Chimeric and humanized monoclonal antibodies specific to VEGF receptors
|
US20030108545A1
(en)
*
|
1994-02-10 |
2003-06-12 |
Patricia Rockwell |
Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
|
US7294331B2
(en)
*
|
1994-03-07 |
2007-11-13 |
Immunex Corporation |
Methods of using flt3-ligand in hematopoietic cell transplantation
|
US6242417B1
(en)
|
1994-03-08 |
2001-06-05 |
Somatogen, Inc. |
Stabilized compositions containing hemoglobin
|
US5631219A
(en)
*
|
1994-03-08 |
1997-05-20 |
Somatogen, Inc. |
Method of stimulating hematopoiesis with hemoglobin
|
US5985660A
(en)
*
|
1994-06-15 |
1999-11-16 |
Systemix, Inc. |
Method of identifying biological response modifiers involved in dendritic and/or lymphoid progenitor cell proliferation and/or differentiation
|
WO1995034676A1
(en)
*
|
1994-06-15 |
1995-12-21 |
Systemix, Inc. |
Population of cells enriched for myeloid and/or lymphoid progenitors and methods of making and using
|
US5972627A
(en)
*
|
1994-06-15 |
1999-10-26 |
Systemix, Inc. |
Method of purifying a population of cells enriched for dendritic and/or lymphoid progenitors and populations of cells obtained thereby
|
US5972703A
(en)
|
1994-08-12 |
1999-10-26 |
The Regents Of The University Of Michigan |
Bone precursor cells: compositions and methods
|
US5474687A
(en)
*
|
1994-08-31 |
1995-12-12 |
Activated Cell Therapy, Inc. |
Methods for enriching CD34+ human hematopoietic progenitor cells
|
US5827742A
(en)
*
|
1994-09-01 |
1998-10-27 |
Beth Israel Deaconess Medical Center, Inc. |
Method of selecting pluripotent hematopioetic progenitor cells
|
US5650317A
(en)
*
|
1994-09-16 |
1997-07-22 |
Michigan State University |
Human breast epithelial cell type with stem cell and luminal epithelial cell characteristics
|
US6140119A
(en)
*
|
1994-09-16 |
2000-10-31 |
Michigan State University |
Expression of estrogen receptors in type I and type II human breast epithelial cells
|
US5686577A
(en)
*
|
1994-10-17 |
1997-11-11 |
Cornell Research Foundation, Inc. |
T cell factors influencing B cell development
|
WO1996015227A1
(en)
*
|
1994-11-14 |
1996-05-23 |
Novartis Ag |
Methods of inducing cell death of primitive hematopoietic cells and compositions for induction thereof
|
US5665557A
(en)
*
|
1994-11-14 |
1997-09-09 |
Systemix, Inc. |
Method of purifying a population of cells enriched for hematopoietic stem cells populations of cells obtained thereby and methods of use thereof
|
US5677136A
(en)
*
|
1994-11-14 |
1997-10-14 |
Systemix, Inc. |
Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
|
US5610056A
(en)
*
|
1994-11-16 |
1997-03-11 |
Amgen Inc. |
Use of stem cell factor interleukin-6 and soluble interleukin-6 receptor to induce the development of hematopoietic stem cells
|
US5874301A
(en)
*
|
1994-11-21 |
1999-02-23 |
National Jewish Center For Immunology And Respiratory Medicine |
Embryonic cell populations and methods to isolate such populations
|
US5665350A
(en)
*
|
1994-11-23 |
1997-09-09 |
University Of Massachusetts Medical Center |
Cell cycle dependent transplantation and ex vivo gene therapy
|
EP0797450A4
(de)
*
|
1994-12-01 |
2000-02-02 |
New England Deaconess Hospital |
In vitro t-lymphopoiese system
|
US5843780A
(en)
*
|
1995-01-20 |
1998-12-01 |
Wisconsin Alumni Research Foundation |
Primate embryonic stem cells
|
US9068164B1
(en)
*
|
1995-02-02 |
2015-06-30 |
Tristem Trading (Cyprus) Limited |
Method of preparing an undifferentiated cell
|
GB9502022D0
(en)
*
|
1995-02-02 |
1995-03-22 |
Abuljadayel Ilham M S |
A method for preparing lymphohaematopoietic progenitor cells
|
US5830755A
(en)
*
|
1995-03-27 |
1998-11-03 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
T-cell receptors and their use in therapeutic and diagnostic methods
|
US5876956A
(en)
*
|
1995-05-15 |
1999-03-02 |
Johns Hopkins University School Of Medicine |
Methods for identification or purification of cells containing an enzymatic intracellular marker
|
US5925567A
(en)
*
|
1995-05-19 |
1999-07-20 |
T. Breeders, Inc. |
Selective expansion of target cell populations
|
US5674750A
(en)
*
|
1995-05-19 |
1997-10-07 |
T. Breeders |
Continuous selective clonogenic expansion of relatively undifferentiated cells
|
US6015554A
(en)
*
|
1995-06-07 |
2000-01-18 |
Systemix, Inc. |
Method of reconstituting human lymphoid and dendritic cells
|
US5861313A
(en)
*
|
1995-06-07 |
1999-01-19 |
Ontogeny, Inc. |
Method of isolating bile duct progenitor cells
|
US5728581A
(en)
*
|
1995-06-07 |
1998-03-17 |
Systemix, Inc. |
Method of expanding hematopoietic stem cells, reagents and bioreactors for use therein
|
WO1996040875A1
(en)
*
|
1995-06-07 |
1996-12-19 |
Novartis Ag |
Methods for obtaining compositions enriched for hematopoietic stem cells and antibodies for use therein
|
US20020182730A1
(en)
*
|
1995-07-26 |
2002-12-05 |
Micheal L. Gruenberg |
Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
|
US7361330B2
(en)
*
|
1995-10-04 |
2008-04-22 |
Immunex Corporation |
Methods of using flt3-ligand in the treatment of fibrosarcoma
|
US7150992B1
(en)
|
1995-10-04 |
2006-12-19 |
Innunex Corporation |
Methods of preparing dendritic cells with flt3-ligand and antigen
|
US20020034517A1
(en)
*
|
1995-10-04 |
2002-03-21 |
Kenneth Brasel |
Dendritic cell stimulatory factor
|
US6060052A
(en)
*
|
1995-10-30 |
2000-05-09 |
Systemix, Inc. |
Methods for use of Mpl ligands with primitive human hematopoietic stem cells
|
US5910434A
(en)
*
|
1995-12-15 |
1999-06-08 |
Systemix, Inc. |
Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant
|
WO1997022708A1
(en)
*
|
1995-12-19 |
1997-06-26 |
Systemix, Inc. |
Primate cluster-forming embryonic hematopoietic stem cells
|
EP0877795A4
(de)
*
|
1996-01-16 |
2003-03-05 |
Depuy Orthopaedics Inc |
Isolierung von vorläuferzellen aus hematopoietischen und nicht hematopoietischen gewebe und deren verwendung
|
JP2000507812A
(ja)
*
|
1996-03-12 |
2000-06-27 |
ライフ テクノロジーズ,インコーポレイテッド |
造血細胞培養栄養補充成分
|
US6455678B1
(en)
*
|
1996-04-26 |
2002-09-24 |
Amcell Corporation |
Human hematopoietic stem and progenitor cell antigen
|
US5843633A
(en)
*
|
1996-04-26 |
1998-12-01 |
Amcell Corporation |
Characterization of a human hematopoietic progenitor cell antigen
|
US5928638A
(en)
*
|
1996-06-17 |
1999-07-27 |
Systemix, Inc. |
Methods for gene transfer
|
US6383480B1
(en)
*
|
1996-07-10 |
2002-05-07 |
Meiji Milk Products, Co., Ltd. |
Composition comprising midkine or pleiotrophin protein and method of increasing hematopoietic cells
|
US7696404B2
(en)
*
|
1996-08-19 |
2010-04-13 |
Advanced Cell Technology, Inc. |
Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions
|
JP2001500725A
(ja)
*
|
1996-08-19 |
2001-01-23 |
ユニヴァーシティー オヴ マサチューセッツ |
種間核移植により製造される胚性または幹細胞様細胞株
|
US5945337A
(en)
|
1996-10-18 |
1999-08-31 |
Quality Biological, Inc. |
Method for culturing CD34+ cells in a serum-free medium
|
AU7180398A
(en)
|
1996-11-13 |
1998-06-03 |
Morphogenesis, Inc. |
Antibody MG1 recognizing a small subset of human hematopoietic cells
|
WO1998025634A1
(en)
*
|
1996-12-10 |
1998-06-18 |
Hadasit Medical Research Services & Development Company Ltd. |
Serum-derived factor inducing cell differentiation and medical uses thereof
|
JP2001524942A
(ja)
*
|
1997-02-24 |
2001-12-04 |
ティーエム テクノロジーズ,インク. |
アンチセンス・オリゴヌクレオチド薬物
|
US6090622A
(en)
*
|
1997-03-31 |
2000-07-18 |
The Johns Hopkins School Of Medicine |
Human embryonic pluripotent germ cells
|
US6331406B1
(en)
|
1997-03-31 |
2001-12-18 |
The John Hopkins University School Of Medicine |
Human enbryonic germ cell and methods of use
|
US5948426A
(en)
*
|
1997-05-03 |
1999-09-07 |
Jefferies; Steven R. |
Method and article to induce hematopoietic expansion
|
US6043066A
(en)
|
1997-09-04 |
2000-03-28 |
Mangano; Joseph A. |
Cell separation using electric fields
|
US6440734B1
(en)
*
|
1998-09-25 |
2002-08-27 |
Cytomatrix, Llc |
Methods and devices for the long-term culture of hematopoietic progenitor cells
|
US6093531A
(en)
|
1997-09-29 |
2000-07-25 |
Neurospheres Holdings Ltd. |
Generation of hematopoietic cells from multipotent neural stem cells
|
US5955257A
(en)
|
1997-10-21 |
1999-09-21 |
Regents Of The University Of Minnesota |
Infusible grade short-term cell storage medium for mononuclear cells
|
ATE426036T1
(de)
*
|
1997-11-14 |
2009-04-15 |
Cedars Sinai Medical Center |
Transfektion und transfer nicht humaner mannlicher keimzellen zur generierung transgener nicht humaner saugetiere
|
US6734338B1
(en)
|
1997-11-14 |
2004-05-11 |
Cedars-Sinai Medical Center |
Transfection, storage and transfer of male germ cells for generation of transgenic species and genetic therapies
|
US7294755B1
(en)
|
1997-11-14 |
2007-11-13 |
Cedars-Sinai Medical Center |
Genetic modification of male germ cells for generation of transgenic species and genetic therapies
|
US6361642B1
(en)
|
1997-12-02 |
2002-03-26 |
Baxter International Inc. |
Heat and pressure-formed flexible containers
|
CA2313250A1
(en)
|
1997-12-04 |
1999-06-10 |
Duke University |
Methods of isolating and using cd7+cd34-lin-hematopoietic cells
|
US6059968A
(en)
*
|
1998-01-20 |
2000-05-09 |
Baxter International Inc. |
Systems for processing and storing placenta/umbilical cord blood
|
WO1999037751A1
(en)
|
1998-01-23 |
1999-07-29 |
Imclone Systems Incorporated |
Purified populations of stem cells
|
US20020034819A1
(en)
*
|
1998-02-23 |
2002-03-21 |
Alan K. Smith |
Human lineage committed cell composition with enhanced proliferative potential, biological effector function, or both; methods for obtaining same; and their uses
|
CA2338344A1
(en)
|
1998-05-29 |
1999-12-02 |
Case Western Reserve University |
Hematopoietic progenitor cell gene transduction
|
US6451558B1
(en)
*
|
1998-08-03 |
2002-09-17 |
Novartis Ag |
Genes in the control of hematopoiesis
|
WO2000011139A1
(en)
*
|
1998-08-24 |
2000-03-02 |
T.Breeders, Inc. |
Cell population containing non-fetal hemangioblasts and method for producing same
|
WO2000014203A1
(fr)
*
|
1998-09-02 |
2000-03-16 |
Chugai Seiyaku Kabushiki Kaisha |
Procede de preparation d'une fraction de cellule contenant des cellules souches hematopoietiques
|
US8297377B2
(en)
*
|
1998-11-20 |
2012-10-30 |
Vitruvian Exploration, Llc |
Method and system for accessing subterranean deposits from the surface and tools therefor
|
DE69939945D1
(de)
*
|
1998-12-07 |
2009-01-02 |
Univ Duke |
Verfahren zur isolierung von stammzellen
|
CA2391657A1
(en)
*
|
1999-01-25 |
2000-07-27 |
Seattle Biomedical Research Institute |
Anti-transforming growth factor beta (tgf-.beta.) treated stem cell composition and method
|
ES2233327T3
(es)
*
|
1999-02-03 |
2005-06-16 |
I.D.M. Immuno-Designed Molecules |
Composicion celular que contiene macrofagos que presenta propiedades antiinfecciosas y hematopoyeticas, y un procedimiento para su preparacion.
|
US6153113A
(en)
*
|
1999-02-22 |
2000-11-28 |
Cobe Laboratories, Inc. |
Method for using ligands in particle separation
|
US6238922B1
(en)
|
1999-02-26 |
2001-05-29 |
Stemcells, Inc. |
Use of collagenase in the preparation of neural stem cell cultures
|
AUPR074500A0
(en)
*
|
2000-10-13 |
2000-11-09 |
Monash University |
Treatment of t cell disorders
|
US20040265285A1
(en)
*
|
1999-04-15 |
2004-12-30 |
Monash University |
Normalization of defective T cell responsiveness through manipulation of thymic regeneration
|
US20040258672A1
(en)
*
|
1999-04-15 |
2004-12-23 |
Monash University |
Graft acceptance through manipulation of thymic regeneration
|
US20040241842A1
(en)
*
|
1999-04-15 |
2004-12-02 |
Monash University |
Stimulation of thymus for vaccination development
|
US20050020524A1
(en)
*
|
1999-04-15 |
2005-01-27 |
Monash University |
Hematopoietic stem cell gene therapy
|
US20040259803A1
(en)
*
|
1999-04-15 |
2004-12-23 |
Monash University |
Disease prevention by reactivation of the thymus
|
US20070274946A1
(en)
*
|
1999-04-15 |
2007-11-29 |
Norwood Immunoloty, Ltd. |
Tolerance to Graft Prior to Thymic Reactivation
|
JP2002542883A
(ja)
*
|
1999-04-30 |
2002-12-17 |
マサチューセッツ ジェネラル ホスピタル |
微細加工した2次元鋳型を用いる血管新生組織の加工
|
US7759113B2
(en)
*
|
1999-04-30 |
2010-07-20 |
The General Hospital Corporation |
Fabrication of tissue lamina using microfabricated two-dimensional molds
|
US6821513B1
(en)
|
1999-06-23 |
2004-11-23 |
Oregon Health & Science University |
Method for enhancing hematopoiesis
|
CA2375527A1
(en)
*
|
1999-06-23 |
2000-12-28 |
Oregon Health And Science University |
Method for enhancing hematopoiesis
|
US7015037B1
(en)
*
|
1999-08-05 |
2006-03-21 |
Regents Of The University Of Minnesota |
Multiponent adult stem cells and methods for isolation
|
US10638734B2
(en)
|
2004-01-05 |
2020-05-05 |
Abt Holding Company |
Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
|
IL147990A0
(en)
|
1999-08-05 |
2002-09-12 |
Mcl Llc |
Multipotent adult stem cells and methods for isolation
|
US8252280B1
(en)
|
1999-08-05 |
2012-08-28 |
Regents Of The University Of Minnesota |
MAPC generation of muscle
|
US7994278B1
(en)
|
1999-08-06 |
2011-08-09 |
Nobel Biosciences Llc |
Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
|
US6749850B1
(en)
|
1999-08-18 |
2004-06-15 |
The General Hospital Corporation |
Methods, compositions and kits for promoting recovery from damage to the central nervous system
|
CA2385628A1
(en)
*
|
1999-09-27 |
2001-04-05 |
Ammon B. Peck |
Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures
|
CN1423523A
(zh)
*
|
1999-11-17 |
2003-06-11 |
罗切斯特大学 |
来自人体内的免疫系统
|
US6790614B1
(en)
|
1999-11-19 |
2004-09-14 |
Novartis Ag |
Selectable cell surface marker genes
|
US7112576B1
(en)
|
1999-12-10 |
2006-09-26 |
Regents Of The University Of Minnesota |
Compositions and methods for cryopreservation of peripheral blood lymphocytes
|
AU784731B2
(en)
*
|
1999-12-20 |
2006-06-08 |
University Of Massachusetts |
Embryonic or stem-like cells produced by cross species nuclear transplantation
|
AU4744201A
(en)
*
|
2000-03-15 |
2001-09-24 |
Childrens Medical Center |
Systemic gene delivery vehicles for the treatment of tumors
|
DK1360500T3
(da)
*
|
2000-04-14 |
2010-05-25 |
Genencor Int |
Fremgangsmåde til selektiv målretning
|
US7129326B2
(en)
*
|
2000-04-14 |
2006-10-31 |
Genencor International, Inc. |
Methods for selective targeting
|
US7776021B2
(en)
*
|
2000-04-28 |
2010-08-17 |
The Charles Stark Draper Laboratory |
Micromachined bilayer unit for filtration of small molecules
|
AR028039A1
(es)
|
2000-05-03 |
2003-04-23 |
Oncolytics Biotech Inc |
Remocion de reovirus de celulas neoplasticas intermediadas por ras a partir de composiciones celulares mixtas
|
AR028040A1
(es)
*
|
2000-05-03 |
2003-04-23 |
Oncolytics Biotech Inc |
Remocion de virus de celulas neoplasticas a partir de composiciones celulares mixtas
|
US8491884B2
(en)
|
2000-05-03 |
2013-07-23 |
Oncolytics Biotech Inc. |
Virus clearance of neoplastic cells from mixed cellular compositions
|
US6828145B2
(en)
*
|
2000-05-10 |
2004-12-07 |
Cedars-Sinai Medical Center |
Method for the isolation of stem cells by immuno-labeling with HLA/MHC gene product marker
|
US20040131585A1
(en)
*
|
2000-06-05 |
2004-07-08 |
Silviu Itescu |
Identification and use og human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
|
FR2810045B1
(fr)
*
|
2000-06-07 |
2004-09-03 |
Assist Publ Hopitaux De Paris |
Procede d'obtention de population cellulaires caracterisees d'origine musculaire et utilisations
|
US6632620B1
(en)
|
2000-06-22 |
2003-10-14 |
Andrew N. Makarovskiy |
Compositions for identification and isolation of stem cells
|
US6984522B2
(en)
*
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
US8044259B2
(en)
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
EP1978090A1
(de)
|
2000-08-09 |
2008-10-08 |
ES Cell International Pte Ltd. |
Pankreatische Vorläuferzellen
|
US20060088512A1
(en)
*
|
2001-10-15 |
2006-04-27 |
Monash University |
Treatment of T cell disorders
|
US20020151050A1
(en)
*
|
2000-10-30 |
2002-10-17 |
Vacanti Charles A. |
Isolation of spore-like cells from tissues exposed to extreme conditions
|
WO2002044343A2
(en)
*
|
2000-11-22 |
2002-06-06 |
Geron Corporation |
Tolerizing allografts of pluripotent stem cells
|
US6576464B2
(en)
|
2000-11-27 |
2003-06-10 |
Geron Corporation |
Methods for providing differentiated stem cells
|
US6921665B2
(en)
|
2000-11-27 |
2005-07-26 |
Roslin Institute (Edinburgh) |
Selective antibody targeting of undifferentiated stem cells
|
WO2002044345A1
(en)
*
|
2000-12-01 |
2002-06-06 |
The General Hospital Corporation |
Methods and products for manipulating hematopoietic stem cells
|
KR100915482B1
(ko)
|
2000-12-06 |
2009-09-03 |
하리리 로버트 제이 |
태반 줄기 세포의 회수 방법
|
US7311905B2
(en)
*
|
2002-02-13 |
2007-12-25 |
Anthrogenesis Corporation |
Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
|
US20080152629A1
(en)
*
|
2000-12-06 |
2008-06-26 |
James Edinger |
Placental stem cell populations
|
US20030147874A1
(en)
*
|
2000-12-14 |
2003-08-07 |
Volker Schellenberger |
Targeted enzyme prodrug therapy
|
US20030068792A1
(en)
*
|
2000-12-14 |
2003-04-10 |
Yiyou Chen |
Targeted enzymes
|
US20030049689A1
(en)
*
|
2000-12-14 |
2003-03-13 |
Cynthia Edwards |
Multifunctional polypeptides
|
US20080248544A1
(en)
*
|
2000-12-14 |
2008-10-09 |
Murray Christopher J |
Methods And Compositions For Grafting Functional Loops Into A Protein
|
AU2002216341A1
(en)
*
|
2000-12-19 |
2002-07-01 |
Insight Strategy And Marketing Ltd. |
The use of ecm degrading enzymes for the improvement of cell transplantation
|
WO2002053193A2
(en)
|
2001-01-02 |
2002-07-11 |
The Charles Stark Draper Laboratory, Inc. |
Tissue engineering of three-dimensional vascularized using microfabricated polymer assembly technology
|
EP1362095B1
(de)
*
|
2001-02-14 |
2015-05-27 |
Anthrogenesis Corporation |
Post-partum säugetier-plazenta, deren verwendung und daraus gewonnene stammzellen
|
EP1367899A4
(de)
*
|
2001-02-14 |
2004-07-28 |
Leo T Furcht |
Multipotente adulte stammzellen, ausgangsmaterial dafür, verfahren zu ihrer gewinnung und erhaltung, differenzierungsmethoden dafür, verfahren zu ihrer verwendung, sowie von ihnen stammende zellen
|
US7723111B2
(en)
*
|
2001-03-09 |
2010-05-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Activated dual specificity lymphocytes and their methods of use
|
FR2821947B1
(fr)
*
|
2001-03-12 |
2003-05-16 |
Canon Kk |
Procede et dispositif de validation de parametres definissant une image
|
EP1385935A4
(de)
*
|
2001-03-29 |
2004-09-15 |
Ixion Biotechnology Inc |
Verfahren zur transdifferenzierung nicht-pankreatischer stammzellen in den pankreatischen differenzierungsweg
|
US20030095952A1
(en)
*
|
2001-06-13 |
2003-05-22 |
Krause Diane S. |
Multi-organ engraftment with a single bone marrow-derived stem cell
|
JP4493882B2
(ja)
*
|
2001-06-19 |
2010-06-30 |
株式会社カネカ |
抗原およびこの抗原を識別するモノクローナル抗体
|
EP1515707A4
(de)
*
|
2001-06-20 |
2005-10-19 |
Imclone Systems Inc |
Verfahren zur behandlung von atherosklerose und anderer entzündlicher erkrankungen
|
US20050026220A1
(en)
*
|
2001-08-10 |
2005-02-03 |
Shahin Rafii |
Isolation and mobilization of stem cells expressing vegfr-1
|
US20030049836A1
(en)
*
|
2001-08-15 |
2003-03-13 |
Phi-Wilson Janette T. |
Cell separation system
|
DE10144326B4
(de)
*
|
2001-09-10 |
2005-09-22 |
Siemens Ag |
Verfahren und System zur Überwachung eines Reifenluftdrucks
|
US20030134415A1
(en)
*
|
2001-09-19 |
2003-07-17 |
Gruenberg Micheal L. |
Th1 cell adoptive immunotherapy
|
US20030134341A1
(en)
*
|
2001-09-19 |
2003-07-17 |
Medcell Biologics, Llc. |
Th1 cell adoptive immunotherapy
|
US9969980B2
(en)
*
|
2001-09-21 |
2018-05-15 |
Garnet Biotherapeutics |
Cell populations which co-express CD49c and CD90
|
EP2266396A3
(de)
|
2001-09-24 |
2011-06-15 |
Sangamo BioSciences, Inc. |
Modulation von stammzellen mittels zinkfingerproteinen
|
US20030119080A1
(en)
*
|
2001-10-15 |
2003-06-26 |
Mangano Joseph A. |
Strategies for the identification and isolation of cancer stem cells and non-cancerous stem cells
|
US7129034B2
(en)
*
|
2001-10-25 |
2006-10-31 |
Cedars-Sinai Medical Center |
Differentiation of whole bone marrow
|
US6759244B2
(en)
|
2001-11-08 |
2004-07-06 |
Art Institute Of New York And New Jersey, Inc. |
Composite blastocysts (CBs) from aggregates of dissociated cells of non-viable pre-embryos
|
US7799324B2
(en)
*
|
2001-12-07 |
2010-09-21 |
Geron Corporation |
Using undifferentiated embryonic stem cells to control the immune system
|
US20040224403A1
(en)
*
|
2001-12-07 |
2004-11-11 |
Robarts Research Institute |
Reconstituting hematopoietic cell function using human embryonic stem cells
|
WO2003050251A2
(en)
|
2001-12-07 |
2003-06-19 |
Geron Corporation |
Hematopoietic cells from human embryonic stem cells
|
JP2005511754A
(ja)
*
|
2001-12-07 |
2005-04-28 |
リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
乳癌幹細胞の予測的同定および特徴づけ
|
US7190781B2
(en)
*
|
2002-01-04 |
2007-03-13 |
Telefonaktiebolaget Lm Ericsson (Publ) |
Message transfer part point code mapping method and node
|
EP1916001B1
(de)
*
|
2002-03-04 |
2011-05-25 |
Imclone LLC |
KDR-spezifische menschliche Antikörper und ihre Verwendung
|
US20030175272A1
(en)
*
|
2002-03-07 |
2003-09-18 |
Medcell Biologics, Inc. |
Re-activated T-cells for adoptive immunotherapy
|
US20030199464A1
(en)
*
|
2002-04-23 |
2003-10-23 |
Silviu Itescu |
Regeneration of endogenous myocardial tissue by induction of neovascularization
|
US20030215935A1
(en)
*
|
2002-05-14 |
2003-11-20 |
Coon David James |
Apparatus and method for isolating living cells from an encapsulated organ tissue sample
|
BRPI0311182A2
(pt)
*
|
2002-05-16 |
2016-06-21 |
Absorber Ab |
método para isolar uma célula endotelial e método para realizar provas cruzadas específicas para o doador
|
US6943021B2
(en)
*
|
2002-06-07 |
2005-09-13 |
Mattek Corporation |
Three dimensional vaginal tissue model containing immune cells
|
EP2107116A3
(de)
|
2002-06-12 |
2009-12-09 |
Genencor International, Inc. |
Verfahren zur Verbesserung der Bindungscharakteristika von Molekülen
|
WO2004009758A2
(en)
*
|
2002-07-23 |
2004-01-29 |
Nanodiagnostics, Inc. |
Embryonic stem cell markers and uses thereof
|
US20110158966A1
(en)
*
|
2002-07-23 |
2011-06-30 |
Judith Seligman |
Stem cells characterized by expression of germline specific genes
|
US7635477B2
(en)
|
2002-07-25 |
2009-12-22 |
The General Hospital Corporation |
Parathyroid hormone receptor activation and stem and progenitor cell expansion
|
AU2003256839B2
(en)
*
|
2002-07-25 |
2009-10-29 |
The General Hospital Corporation |
Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion
|
US20040028661A1
(en)
*
|
2002-08-07 |
2004-02-12 |
Bartelmez Stephen H. |
Expansion of cells using thrombopoietin and anti-transforming growth factor-beta
|
IL166636A0
(en)
*
|
2002-08-09 |
2006-01-15 |
Innovationsagentur |
Method for producing cell lines and organs by means of differentiable cells
|
US20050271639A1
(en)
|
2002-08-22 |
2005-12-08 |
Penn Marc S |
Genetically engineered cells for therapeutic applications
|
US20040077985A1
(en)
*
|
2002-09-03 |
2004-04-22 |
Donnie Rudd |
Method of replenishing cells damaged by treatment for cancer
|
US20040044300A1
(en)
*
|
2002-09-03 |
2004-03-04 |
Donnie Rudd |
Method of replenishing cells damaged by treatment for cancer
|
US9969977B2
(en)
*
|
2002-09-20 |
2018-05-15 |
Garnet Biotherapeutics |
Cell populations which co-express CD49c and CD90
|
CN102304570B
(zh)
|
2002-11-13 |
2015-01-21 |
托马斯杰斐逊大学 |
用于癌症诊断和治疗的组合物和方法
|
AU2003295444A1
(en)
*
|
2002-11-15 |
2004-06-15 |
The Board Of Trustees Of The University Of Illinois |
Methods for in vitro expansion of hematopoietic stem cells
|
EP1571910A4
(de)
|
2002-11-26 |
2009-10-28 |
Anthrogenesis Corp |
Zytotherapeutika, zytotherapeutischeeinheiten und behandlungsverfahren, bei denen diese verwendet werden
|
US20040110286A1
(en)
*
|
2002-12-06 |
2004-06-10 |
The John P. Robarts Research Institute |
Method for making hematopoietic cells
|
WO2004065616A2
(en)
|
2003-01-16 |
2004-08-05 |
The General Hospital Corporation |
Use of three-dimensional microfabricated tissue engineered systems for pharmacologic applications
|
NZ542127A
(en)
*
|
2003-02-13 |
2008-04-30 |
Anthrogenesis Corp |
Use of umbilical cord blood to treat individuals having a disease, disorder or condition
|
US20070020242A1
(en)
*
|
2003-03-27 |
2007-01-25 |
Ixion Biotechnology, Inc. |
Method for transdifferentiation of non-pancreatic stem cells to the pancreatic pathway
|
US7960166B2
(en)
|
2003-05-21 |
2011-06-14 |
The General Hospital Corporation |
Microfabricated compositions and processes for engineering tissues containing multiple cell types
|
US20060019256A1
(en)
*
|
2003-06-09 |
2006-01-26 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
WO2006040615A2
(en)
*
|
2003-06-11 |
2006-04-20 |
Jan Remmereit |
Differenciation of stem cells for therapeutic use
|
US9441244B2
(en)
|
2003-06-30 |
2016-09-13 |
The Regents Of The University Of California |
Mutant adeno-associated virus virions and methods of use thereof
|
US20060162014A1
(en)
|
2003-07-07 |
2006-07-20 |
Jaffe Eileen K |
Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules
|
US8153410B2
(en)
*
|
2003-07-07 |
2012-04-10 |
Fox Chase Cancer Center |
Alternate morpheein forms of allosteric proteins as a target for the development of bioactive molecules
|
EP2927318B1
(de)
|
2003-08-08 |
2020-05-20 |
Sangamo Therapeutics, Inc. |
Verfahren und Zusammensetzungen für gezielte Spaltung und Rekombination
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
US7569385B2
(en)
*
|
2003-08-14 |
2009-08-04 |
The Regents Of The University Of California |
Multipotent amniotic fetal stem cells
|
GB0321337D0
(en)
*
|
2003-09-11 |
2003-10-15 |
Massone Mobile Advertising Sys |
Method and system for distributing advertisements
|
WO2005027841A2
(en)
*
|
2003-09-16 |
2005-03-31 |
University Of North Carolina At Chapel Hill |
Cells, compositions and methods for repressing b cell autoantibody secretion and for treating autoimmune disease
|
EP1687411B1
(de)
*
|
2003-09-26 |
2015-05-06 |
The Regents Of The University Of Michigan |
Identifizierung und isolierung hämatopoetischer stammzellen
|
CA2545248A1
(en)
*
|
2003-09-29 |
2005-04-14 |
The Regents Of The University Of California |
Methods for altering hematopoietic progenitor cell adhesion, differentiation, and migration
|
AU2004291559B2
(en)
*
|
2003-11-19 |
2008-10-16 |
Australian Stem Cell Centre Limited |
Methods for producing blood products from pluripotent cells in cell culture
|
KR20110116225A
(ko)
*
|
2003-12-02 |
2011-10-25 |
셀진 코포레이션 |
혈색소병증 및 빈혈의 치료 및 관리를 위한 방법및 조성물
|
US20080279812A1
(en)
*
|
2003-12-05 |
2008-11-13 |
Norwood Immunology, Ltd. |
Disease Prevention and Vaccination Prior to Thymic Reactivation
|
US8147806B2
(en)
|
2004-01-16 |
2012-04-03 |
Carnegie Mellon University |
Cellular labeling for nuclear magnetic resonance techniques
|
WO2005074633A2
(en)
*
|
2004-02-03 |
2005-08-18 |
The Regents Of The University Of Michigan |
Compositions and methods for characterizing, regulating, diagnosing, and treating cancer
|
EP1718735A1
(de)
|
2004-02-11 |
2006-11-08 |
Aldagen, Inc. |
Stammzellpopulationen und verwendungsverfahren
|
DE602005023592D1
(de)
*
|
2004-03-09 |
2010-10-28 |
Absorber Ab |
Endothelvorläuferzellen und verfahren zur verwendung davon
|
DE602005023426D1
(de)
*
|
2004-03-25 |
2010-10-21 |
California Inst Of Techn |
Hybridisierungskettenreaktion
|
CN101080486B
(zh)
*
|
2004-04-23 |
2012-05-16 |
佰欧益股份有限公司 |
多谱系祖细胞
|
US7622108B2
(en)
*
|
2004-04-23 |
2009-11-24 |
Bioe, Inc. |
Multi-lineage progenitor cells
|
WO2005113751A1
(en)
|
2004-05-14 |
2005-12-01 |
Becton, Dickinson And Company |
Cell culture environments for the serum-free expansion of mesenchymal stem cells
|
US20080233100A1
(en)
*
|
2004-06-30 |
2008-09-25 |
Yiyou Chen |
Targeted enzymes
|
EP1773981A1
(de)
*
|
2004-07-12 |
2007-04-18 |
Sorin Group Italia S.R.L. |
Vorrichtung und verfahren zur anzucht menschlicher zellen
|
US8906637B2
(en)
*
|
2004-09-10 |
2014-12-09 |
Danisco Us Inc. |
Methods for detecting targets
|
DK1800136T3
(da)
*
|
2004-10-15 |
2012-03-26 |
Danisco Us Inc |
Kompetitiv differentiel screening
|
WO2007001420A2
(en)
*
|
2004-10-22 |
2007-01-04 |
Genencor International, Inc. |
Isolating human antibodies
|
EP2626415A3
(de)
|
2004-10-25 |
2014-04-16 |
Cellerant Therapeutics, Inc. |
Verfahren zur Erweiterung von Myeloidzellpopulationen und Verwendungen dafür
|
JP5500773B2
(ja)
|
2004-11-11 |
2014-05-21 |
ザ ジェネラル ホスピタル コーポレーション |
副甲状腺ホルモン受容体の活性化並びに幹細胞及び前駆細胞の増殖
|
CA2590671A1
(en)
*
|
2004-11-18 |
2006-05-26 |
Imclone Systems Incorporated |
Antibodies against vascular endothelial growth factor receptor-1
|
US20080044400A1
(en)
*
|
2004-12-09 |
2008-02-21 |
Volker Schellenberger |
Targeted enzyme prodrug therapy
|
GB0503918D0
(en)
*
|
2005-02-25 |
2005-04-06 |
Erasmus University |
Cell
|
US7727721B2
(en)
*
|
2005-03-08 |
2010-06-01 |
California Institute Of Technology |
Hybridization chain reaction amplification for in situ imaging
|
US20060252073A1
(en)
*
|
2005-04-18 |
2006-11-09 |
Regents Of The University Of Michigan |
Compositions and methods for the treatment of cancer
|
US20060269527A1
(en)
*
|
2005-05-26 |
2006-11-30 |
Australian Stem Cell Centre Limited |
Isolation of cells from bone
|
CA2612021A1
(en)
*
|
2005-06-13 |
2006-12-28 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
WO2006135886A2
(en)
*
|
2005-06-13 |
2006-12-21 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
KR101419729B1
(ko)
*
|
2005-07-26 |
2014-07-17 |
상가모 바이오사이언스 인코포레이티드 |
외래 핵산 서열의 표적화된 통합 및 발현
|
BRPI0614470A2
(pt)
*
|
2005-08-01 |
2011-03-29 |
Nupotential Inc |
produção de celulas reprogamadas com potencial restaurado
|
EP1924606A4
(de)
|
2005-08-25 |
2010-01-13 |
Repair Technologies Inc |
Vorrichtungen, zusammensetzungen und verfahren zum schutz und zur reparatur von zellen und gewebe
|
EP1937280B1
(de)
|
2005-09-12 |
2014-08-27 |
The Ohio State University Research Foundation |
Zusammensetzungen zur Therapie von Bcl2-assoziierten Tumoren
|
US7960357B2
(en)
*
|
2005-10-07 |
2011-06-14 |
California Institute Of Technology |
PKR activation via hybridization chain reaction
|
US7462485B2
(en)
*
|
2005-10-07 |
2008-12-09 |
Glaser Lawrence F |
Modified erythrocytes and uses thereof
|
ES2452595T3
(es)
|
2005-10-13 |
2014-04-02 |
Anthrogenesis Corporation |
Inmunomodulación usando células madre de la placenta
|
ES2618785T3
(es)
|
2005-10-31 |
2017-06-22 |
Oncomed Pharmaceuticals, Inc. |
Composiciones y métodos para tratar el cáncer basados en receptores FZD humanos
|
EP1945754B1
(de)
*
|
2005-10-31 |
2014-07-23 |
The Regents Of The University Of Michigan |
Zusammensetzungen und verfahren zur behandlung und diagnostizierung von krebs
|
US7723477B2
(en)
|
2005-10-31 |
2010-05-25 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
|
EP2441461B1
(de)
*
|
2005-11-07 |
2014-05-07 |
Amorcyte, Inc. |
Zusammensetzungen und Verfahren zur Reparatur einer Gefäßverletzung
|
US9034316B2
(en)
*
|
2006-10-24 |
2015-05-19 |
Amorcyte, Llc |
Infarct area perfusion-improving compositions and methods of vascular injury repair
|
US8637005B2
(en)
|
2005-11-07 |
2014-01-28 |
Amorcyte, Inc. |
Compositions and methods of vascular injury repair
|
US20110076255A1
(en)
|
2005-11-07 |
2011-03-31 |
Pecora Andrew L |
Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
|
US9155762B2
(en)
*
|
2005-12-08 |
2015-10-13 |
University Of Louisville Research Foundation, Inc. |
Uses and isolation of stem cells from bone marrow
|
CN101573441A
(zh)
*
|
2005-12-08 |
2009-11-04 |
路易斯维尔大学研究基金会有限公司 |
非常小的胚胎样(vsel)干细胞及分离和利用其的方法
|
US8455250B2
(en)
|
2005-12-29 |
2013-06-04 |
Anthrogenesis Corporation |
Co-culture of placental stem cells and stem cells from a second source
|
PL2471904T3
(pl)
|
2005-12-29 |
2019-08-30 |
Celularity, Inc. |
Populacje komórek macierzystych łożyska
|
WO2007095594A2
(en)
*
|
2006-02-14 |
2007-08-23 |
Cellerant Therapeutics, Inc. |
Methods and compositions for enhancing engraftment of hematopoietic stem cells
|
GEP20135796B
(en)
|
2006-03-07 |
2013-04-10 |
|
Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
|
US20100297087A1
(en)
*
|
2006-04-11 |
2010-11-25 |
Nanodiagnostics Israel., Ltd |
Pluripotent stem cells characterized by expression of germline specific genes
|
WO2007120911A2
(en)
*
|
2006-04-14 |
2007-10-25 |
Carnegie Mellon University |
Cellular labeling and quantification for nuclear magnetic resonance techniques
|
WO2008054509A2
(en)
*
|
2006-04-14 |
2008-05-08 |
Celsense, Inc. |
Methods for assessing cell labeling
|
EP2019858B1
(de)
*
|
2006-04-17 |
2012-06-13 |
BioE LLC |
Differenzierung von vorläuferzellen mit mehreren abstammungslinien in respiratorischen epithelzellen
|
CA2651856C
(en)
|
2006-05-11 |
2015-09-29 |
Regenics As |
Administration of cells and cellular extracts for rejuvenation
|
WO2007146106A2
(en)
*
|
2006-06-05 |
2007-12-21 |
Cryo- Cell International, Inc. |
Procurement, isolation and cryopreservation of maternal placental cells
|
US20080050814A1
(en)
*
|
2006-06-05 |
2008-02-28 |
Cryo-Cell International, Inc. |
Procurement, isolation and cryopreservation of fetal placental cells
|
EP2054506A1
(de)
|
2006-08-15 |
2009-05-06 |
Agency for Science, Technology and Research |
Konditioniertes mesenchym-stammzellen-medium
|
US8785193B2
(en)
|
2006-09-14 |
2014-07-22 |
The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Dissection tool and methods of use
|
WO2008036374A2
(en)
*
|
2006-09-21 |
2008-03-27 |
Medistem Laboratories, Inc. |
Allogeneic stem cell transplants in non-conditioned recipients
|
WO2008039874A2
(en)
|
2006-09-26 |
2008-04-03 |
Cedars-Sinai Medical Center |
Cancer stem cell antigen vaccines and methods
|
DK2086556T3
(da)
*
|
2006-11-03 |
2011-05-09 |
Aastrom Biosciences Inc |
Populationer af blandede celler til vævsreparation og separationsteknik til cellebehandling
|
WO2008066658A2
(en)
|
2006-11-03 |
2008-06-05 |
The Trustees Of Princeton University |
Engineered cellular pathways for programmed autoregulation of differentiation
|
WO2008063675A2
(en)
*
|
2006-11-24 |
2008-05-29 |
Regents Of The University Of Minnesota |
Endodermal progenitor cells
|
WO2008070861A2
(en)
*
|
2006-12-07 |
2008-06-12 |
Cellerant Therapeutics Inc. |
Methods and compositions for treating systemic lupus erythematosus
|
US20100172882A1
(en)
*
|
2007-01-11 |
2010-07-08 |
Glazer Peter M |
Compositions and methods for targeted inactivation of hiv cell surface receptors
|
AU2008206885B2
(en)
|
2007-01-18 |
2011-02-03 |
Glykos Finland Oy |
Novel carbohydrate from human cells and methods for analysis and modification thereof
|
WO2008087257A1
(en)
|
2007-01-18 |
2008-07-24 |
Suomen Punainen Risti, Veripalvelu |
Novel methods and reagents directed to production of cells
|
US8148147B2
(en)
*
|
2007-01-24 |
2012-04-03 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing pancreatic cancer
|
EP2129775A1
(de)
*
|
2007-02-12 |
2009-12-09 |
Anthrogenesis Corporation |
Hepatocyten und chondrocyten aus adhärenten plazentastammzellen sowie cd34+, cd45- plazentastammzellenangereicherte zellpopulationen
|
AU2008216749B2
(en)
|
2007-02-12 |
2014-03-13 |
Celularity Inc. |
Treatment of inflammatory diseases using placental stem cells
|
WO2008106551A2
(en)
|
2007-02-28 |
2008-09-04 |
The Govt. Of The U.S.A. As Represented By The Secretary Of The Dept. Of Health & Human Serv. |
Brachyury polypeptides and methods for use
|
US8318921B2
(en)
*
|
2007-03-01 |
2012-11-27 |
California Institute Of Technology |
Triggered RNAi
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
US20100172830A1
(en)
*
|
2007-03-29 |
2010-07-08 |
Cellx Inc. |
Extraembryonic Tissue cells and method of use thereof
|
US8574567B2
(en)
*
|
2007-05-03 |
2013-11-05 |
The Brigham And Women's Hospital, Inc. |
Multipotent stem cells and uses thereof
|
WO2008137115A1
(en)
|
2007-05-03 |
2008-11-13 |
The Brigham And Women's Hospital, Inc. |
Multipotent stem cells and uses thereof
|
WO2008137641A2
(en)
*
|
2007-05-04 |
2008-11-13 |
Whitehead Institute For Biomedical Research |
Ex vivo expansion of human hematopoietic stem cells
|
US9217151B2
(en)
|
2007-05-16 |
2015-12-22 |
California Institute Of Technology |
Versatile nucleic acid hairpin motif for programming biomolecular self-assembly pathways
|
TWM322542U
(en)
*
|
2007-05-23 |
2007-11-21 |
Universal Scient Ind Co Ltd |
Testing machine
|
WO2008156728A1
(en)
*
|
2007-06-15 |
2008-12-24 |
Neuronyx, Inc. |
Treatment of diseases and disorders using self-renewing colony forming cells cultured and expanded in vitro
|
JP5645658B2
(ja)
*
|
2007-07-10 |
2014-12-24 |
カーネギー メロン ユニバーシティー |
核磁気共鳴技術のための細胞標識を製造するための組成物及び方法
|
US20090029463A1
(en)
*
|
2007-07-25 |
2009-01-29 |
Bioe, Inc. |
Differentiation of Multi-Lineage Progenitor Cells to Chondrocytes
|
US9200253B1
(en)
|
2007-08-06 |
2015-12-01 |
Anthrogenesis Corporation |
Method of producing erythrocytes
|
KR20220122774A
(ko)
*
|
2007-09-26 |
2022-09-02 |
셀룰래리티 인코포레이티드 |
인간 태반 관류액으로부터의 혈관형성 세포
|
EP2783692B1
(de)
|
2007-09-28 |
2019-01-02 |
Celularity, Inc. |
Tumorsuppression mit menschlichem Plazentaperfusat und menschlichen natürlichen Killerzellen eines Zwischenproduktes aus der Plazenta
|
EP2214497A4
(de)
|
2007-10-30 |
2010-11-24 |
Univ Louisville Res Found |
Verwendungen und isolation von vsel (very small embryonic-like) stammzellen
|
US8431162B2
(en)
*
|
2007-10-30 |
2013-04-30 |
University Of Louisville Research Foundation, Inc. |
Subpopulations of bone marrow-derived adherent stem cells and methods of use therefor
|
MX2010005018A
(es)
*
|
2007-11-07 |
2010-05-27 |
Anthrogenesis Corp |
Tratamiento de complicaciones de nacimiento prematuro.
|
AU2009212747B2
(en)
|
2008-01-31 |
2013-11-07 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Engineered antibody constant domain molecules
|
US8497364B2
(en)
*
|
2008-02-27 |
2013-07-30 |
California Institute Of Technology |
Triggered RNAi
|
WO2009116951A2
(en)
|
2008-03-17 |
2009-09-24 |
Agency For Science, Technology And Research |
Microcarriers for stem cell culture
|
AU2009229153B2
(en)
|
2008-03-28 |
2015-06-11 |
Stemcyte, Inc. |
Treatment of brain damage using umbilical cord blood cells
|
CA2723171C
(en)
*
|
2008-05-02 |
2018-03-27 |
Celsense, Inc. |
Emulsion compositions and methods for nuclear magnetic resonance and other imaging
|
WO2009136291A2
(en)
|
2008-05-09 |
2009-11-12 |
Regenics As |
Cellular extracts
|
US20100021904A1
(en)
*
|
2008-05-21 |
2010-01-28 |
Pierce Niles A |
Shielded cross-linking probes
|
CA2724839A1
(en)
*
|
2008-05-21 |
2009-11-26 |
Bioe Llc |
Differentiation of multi-lineage progenitor cells to pancreatic cells
|
US20100021901A1
(en)
*
|
2008-05-22 |
2010-01-28 |
Peng Yin |
Compositions and methods for detecting analytes
|
US8241854B2
(en)
|
2008-05-22 |
2012-08-14 |
California Institute Of Technology |
Triggered RNAi
|
US11291686B2
(en)
|
2008-05-30 |
2022-04-05 |
University Of Louisville Research Foundation, Inc. |
Human facilitating cells
|
US8632768B2
(en)
*
|
2008-05-30 |
2014-01-21 |
University Of Louisville Research Foundation, Inc. |
Human facilitating cells
|
DK2318832T3
(da)
|
2008-07-15 |
2014-01-20 |
Academia Sinica |
Glycan-arrays på PTFE-lignende aluminiumcoatede objektglas og relaterede fremgangsmåder
|
CN105796602A
(zh)
|
2008-08-20 |
2016-07-27 |
人类起源公司 |
利用分离的胎盘细胞治疗中风
|
MX2011001990A
(es)
|
2008-08-20 |
2011-03-29 |
Anthrogenesis Corp |
Composiciones mejoradas de celulas y metodos para preparar las mismas.
|
CN102176919A
(zh)
|
2008-08-22 |
2011-09-07 |
人类起源公司 |
用胎盘细胞群治疗骨缺损的方法和组合物
|
EP2353008A2
(de)
|
2008-09-22 |
2011-08-10 |
Oregon Health and Science University |
Verfahren zum nachweis einer infektion mit mycobacterium tuberculosis
|
PT2331136T
(pt)
|
2008-09-26 |
2018-03-27 |
Oncomed Pharm Inc |
Agentes de ligação a frizzled e utilizações dos mesmos
|
WO2010045495A2
(en)
|
2008-10-16 |
2010-04-22 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof
|
KR20110086176A
(ko)
|
2008-11-19 |
2011-07-27 |
안트로제네시스 코포레이션 |
양막 유래 부착성 세포
|
MX2011005230A
(es)
*
|
2008-11-21 |
2011-06-16 |
Anthrogenesis Corp |
Tratamiento de enfermedades, desordenes o condiciones del pulmon usando celulas de placenta.
|
CA2747418A1
(en)
|
2008-12-16 |
2010-07-01 |
Onconova Therapeutics, Inc. |
Methods for determining efficacy of a therapeutic regimen against deleterious effects of cytotoxic agents
|
WO2010099472A2
(en)
|
2009-02-27 |
2010-09-02 |
The U.S.A. Of America, As Represented By The Secretary, Department Of Health And Human Services |
Spanx-b polypeptides and their use
|
US20100239539A1
(en)
*
|
2009-03-23 |
2010-09-23 |
Sing George L |
Methods for promoting differentiation and differentiation efficiency
|
CA2767014C
(en)
*
|
2009-07-02 |
2022-01-25 |
Anthrogenesis Corporation |
Method of producing erythrocytes without feeder cells
|
ES2546663T3
(es)
|
2009-07-15 |
2015-09-25 |
Calimmune Inc. |
Vector dual para la inhibición del virus de la inmunodeficiencia humana
|
AU2010276201B2
(en)
|
2009-07-21 |
2013-10-17 |
Abt Holding Company |
Use of stem cells to reduce leukocyte extravasation
|
DK2462230T3
(en)
*
|
2009-08-03 |
2015-10-19 |
Recombinetics Inc |
METHODS AND COMPOSITIONS FOR TARGETED RE-MODIFICATION
|
US20110268810A1
(en)
|
2009-11-02 |
2011-11-03 |
Yale University |
Polymeric materials loaded with mutagenic and recombinagenic nucleic acids
|
WO2011060135A1
(en)
|
2009-11-12 |
2011-05-19 |
Vbi Technologies, Llc |
Subpopulations of spore-like cells and uses thereof
|
CN102713629B
(zh)
|
2009-11-20 |
2016-02-24 |
俄勒冈健康科学大学 |
用于检测结核分枝杆菌感染的方法
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
TWI535445B
(zh)
|
2010-01-12 |
2016-06-01 |
安可美德藥物股份有限公司 |
Wnt拮抗劑及治療和篩選方法
|
ES2646750T3
(es)
|
2010-01-26 |
2017-12-15 |
Anthrogenesis Corporation |
Tratamiento de cánceres relacionados con hueso utilizando células madre placentarias
|
AU2011220721B2
(en)
|
2010-02-25 |
2015-02-05 |
Abt Holding Company |
Modulation of macrophage activation
|
KR20130043102A
(ko)
|
2010-04-01 |
2013-04-29 |
온코메드 파마슈티칼스, 인크. |
프리즐드-결합 작용제 및 그의 용도
|
SI2556145T1
(sl)
|
2010-04-07 |
2017-01-31 |
Anthrogenesis Corporation |
Angiogeneza z uporabo placentnih matičnih celic
|
KR20130092394A
(ko)
|
2010-04-08 |
2013-08-20 |
안트로제네시스 코포레이션 |
태반 줄기 세포를 사용한 사르코이드증의 치료
|
US9746459B2
(en)
|
2010-04-08 |
2017-08-29 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Antigen presenting cell assay
|
WO2011127360A1
(en)
|
2010-04-08 |
2011-10-13 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
B-cell antigen presenting cell assay
|
WO2011130332A1
(en)
|
2010-04-12 |
2011-10-20 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
WO2011133803A1
(en)
|
2010-04-21 |
2011-10-27 |
Helix Therapeutics, Inc. |
Compositions and methods for targeted inactivation of hiv cell surface receptors
|
WO2011133802A1
(en)
|
2010-04-21 |
2011-10-27 |
Helix Therapeutics, Inc. |
Compositions and methods for treatment of lysosomal storage disorders
|
JP5841322B2
(ja)
|
2010-04-22 |
2016-01-13 |
オレゴン ヘルス アンド サイエンス ユニバーシティ |
フマリルアセト酢酸ヒドロラーゼ(fah)欠損性ブタおよびその使用
|
ES2699630T3
(es)
|
2010-04-23 |
2019-02-12 |
Cold Spring Harbor Laboratory |
Novedosos ARNhc diseñados estructuralmente
|
WO2011138687A2
(en)
|
2010-05-06 |
2011-11-10 |
Regenics As |
Use of cellular extracts for skin rejuvenation
|
US8658780B2
(en)
|
2010-05-18 |
2014-02-25 |
California Institute Of Technology |
Triggered covalent probes for imaging and silencing genetic expression
|
EP2582793B1
(de)
|
2010-06-15 |
2017-09-06 |
Cellular Dynamics International, Inc. |
Kompendium aus fertig gebauten stammzellmodellen zur abfrage biologischer reaktionen
|
EP2582727B8
(de)
|
2010-06-16 |
2017-04-19 |
University of Pittsburgh- Of the Commonwealth System of Higher Education |
Antikörper zu endoplasmin und deren verwendung
|
JP5897002B2
(ja)
|
2010-07-07 |
2016-04-13 |
セルラー ダイナミクス インターナショナル, インコーポレイテッド |
プログラミングによる内皮細胞の産生
|
NZ605505A
(en)
|
2010-07-13 |
2015-02-27 |
Anthrogenesis Corp |
Methods of generating natural killer cells
|
US8877438B2
(en)
|
2010-07-20 |
2014-11-04 |
California Institute Of Technology |
Self-assembled polynucleotide structure
|
US9834439B2
(en)
|
2010-07-20 |
2017-12-05 |
California Institute Of Technology |
Biomolecular self-assembly
|
US8962241B2
(en)
|
2010-07-20 |
2015-02-24 |
California Institute Of Technology |
Triggered molecular geometry based bioimaging probes
|
JP6047489B2
(ja)
|
2010-08-12 |
2016-12-21 |
フェイト セラピューティクス,インコーポレイテッド |
改善された造血幹細胞および前駆細胞療法
|
EP2625264B1
(de)
|
2010-10-08 |
2022-12-07 |
Terumo BCT, Inc. |
Verfahren und systeme für züchtung und ernte von zellen in einem hohlfaser-bioreaktorsystem mit steuerungsbedingungen
|
US8574899B2
(en)
|
2010-12-22 |
2013-11-05 |
Vladimir B Serikov |
Methods for augmentation collection of placental hematopoietic stem cells and uses thereof
|
JP2014504503A
(ja)
|
2010-12-28 |
2014-02-24 |
ゾーマ テクノロジー リミテッド |
Pdzドメインを用いた細胞表面提示
|
AR093183A1
(es)
|
2010-12-31 |
2015-05-27 |
Anthrogenesis Corp |
Aumento de la potencia de celulas madre de placenta usando moleculas de arn moduladoras
|
WO2012109208A2
(en)
|
2011-02-08 |
2012-08-16 |
Cellular Dynamics International, Inc. |
Hematopoietic precursor cell production by programming
|
US9150644B2
(en)
|
2011-04-12 |
2015-10-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
|
EP2699603B1
(de)
|
2011-04-19 |
2016-03-02 |
The United States of America As Represented by the Secretary Department of Health and Human Services |
Für glypican-3 spezifische humane monoklonale antikörper und ihre verwendung
|
EP3443968A1
(de)
|
2011-06-01 |
2019-02-20 |
Celularity, Inc. |
Schmerzbehandlung mithilfe von stammzellen aus der plazenta
|
DK2718416T3
(da)
|
2011-06-06 |
2020-02-24 |
ReGenesys BVBA |
Ekspansion af stamceller i hulfiberbioreaktorer
|
RU2014100160A
(ru)
|
2011-06-10 |
2015-07-20 |
Блуберд Байо, Инк. |
Векторы генной терапии адренолейкодистрофии и адреномиелонейропатии
|
AU2012284365B2
(en)
|
2011-07-15 |
2017-04-20 |
The General Hospital Corporation |
Methods of transcription activator like effector assembly
|
JP6484444B2
(ja)
|
2011-08-26 |
2019-03-13 |
イエキュリス コーポレーションYecuris Corporation |
フマリルアセト酢酸ヒドロラーゼ(fah)欠損及び免疫不全ラット、並びにそれらの使用
|
US9925221B2
(en)
|
2011-09-09 |
2018-03-27 |
Celularity, Inc. |
Treatment of amyotrophic lateral sclerosis using placental stem cells
|
US9783822B2
(en)
|
2011-09-23 |
2017-10-10 |
Bluebird Bio, Inc. |
Gene therapy methods
|
UA114796C2
(uk)
|
2011-09-30 |
2017-08-10 |
Блубьод Байо, Інк. |
Спосіб підвищення ефективності трансдукції
|
CN112410298A
(zh)
|
2011-12-02 |
2021-02-26 |
菲特治疗公司 |
增强的干细胞组合物
|
EP3381456A1
(de)
|
2011-12-02 |
2018-10-03 |
Fate Therapeutics, Inc. |
Verbesserte verfahren zur behandlung von ischämie
|
TWI443107B
(zh)
|
2011-12-29 |
2014-07-01 |
Ind Tech Res Inst |
人源化之抗人類細胞表面抗原cd34之單株抗體及其應用
|
US9676857B2
(en)
|
2012-03-16 |
2017-06-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Soluble engineered monomeric Fc
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
JP6494507B2
(ja)
|
2012-06-01 |
2019-04-03 |
ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
グリピカン−3に対する高親和性モノクローナル抗体およびその使用
|
CN104936603A
(zh)
|
2012-08-01 |
2015-09-23 |
联合治疗公司 |
利用前列环素处理的内皮祖细胞的肺动脉高血压的治疗
|
CN111803523A
(zh)
|
2012-08-01 |
2020-10-23 |
联合治疗公司 |
利用间充质干细胞的肺动脉高血压的治疗
|
AU2013306098A1
(en)
|
2012-08-18 |
2015-02-12 |
Academia Sinica |
Cell-permeable probes for identification and imaging of sialidases
|
US9409992B2
(en)
|
2012-08-21 |
2016-08-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Mesothelin domain-specific monoclonal antibodies and use thereof
|
WO2014052064A1
(en)
|
2012-09-27 |
2014-04-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Mesothelin antibodies and methods for eliciting potent antitumor activity
|
AU2013334790A1
(en)
|
2012-10-23 |
2015-04-30 |
Oncomed Pharmaceuticals, Inc. |
Methods of treating neuroendocrine tumors using Wnt pathway-binding agents
|
ES2884925T3
(es)
|
2012-11-27 |
2021-12-13 |
Childrens Medical Ct Corp |
Elementos reguladores distales de BCL11A como dianas para la reinducción de la hemoglobina fetal
|
US11007385B2
(en)
|
2012-12-10 |
2021-05-18 |
Regenics As |
Use of cellular extracts for skin rejuvenation
|
ES2697573T3
(es)
|
2013-01-09 |
2019-01-25 |
United Therapeutics Corp |
Tratamiento de la vasculopatía con prostaciclina y células madre mesenquimatosas
|
US9783783B2
(en)
|
2013-01-30 |
2017-10-10 |
Cornell University |
Compositions and methods for the expansion of stem cells
|
JP2016510411A
(ja)
|
2013-02-04 |
2016-04-07 |
オンコメッド ファーマシューティカルズ インコーポレイテッド |
Wnt経路インヒビターによる処置の方法およびモニタリング
|
AU2014215458A1
(en)
|
2013-02-05 |
2015-08-13 |
Anthrogenesis Corporation |
Natural killer cells from placenta
|
WO2014130770A1
(en)
|
2013-02-22 |
2014-08-28 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
US9168300B2
(en)
|
2013-03-14 |
2015-10-27 |
Oncomed Pharmaceuticals, Inc. |
MET-binding agents and uses thereof
|
US9943545B2
(en)
|
2013-03-15 |
2018-04-17 |
Fate Therapeutics, Inc. |
Stem cell culture media and methods of enhancing cell survival
|
EP2968416A4
(de)
|
2013-03-15 |
2016-08-17 |
Fate Therapeutics Inc |
Zellpotenztest für therapeutisches potenzial
|
AU2014248167B2
(en)
|
2013-04-03 |
2019-10-10 |
FUJIFILM Cellular Dynamics, Inc. |
Methods and compositions for culturing endoderm progenitor cells in suspension
|
HUE052516T2
(hu)
|
2013-04-12 |
2021-05-28 |
Houston Methodist Hospital |
Szervek javítása transzplantációhoz
|
AU2014266935B2
(en)
|
2013-04-30 |
2020-06-11 |
Katholieke Universiteit Leuven |
Cell therapy for myelodysplastic syndromes
|
US9758763B2
(en)
|
2013-05-29 |
2017-09-12 |
The Regents Of The University Of California |
Methods and compositions for somatic cell proliferation and viability
|
EP3013365B1
(de)
|
2013-06-26 |
2019-06-05 |
Academia Sinica |
Rm2-antigene und verwendung davon
|
WO2014210564A1
(en)
|
2013-06-27 |
2014-12-31 |
Academia Sinica |
Glycan conjugates and use thereof
|
US9856472B2
(en)
|
2013-07-01 |
2018-01-02 |
California Institute Of Technology |
Small conditional RNAs
|
CN105682666B
(zh)
|
2013-09-06 |
2021-06-01 |
中央研究院 |
使用醣脂激活人类iNKT细胞
|
CA2927730A1
(en)
|
2013-10-15 |
2015-05-07 |
Case Western Reserve University |
Compositions and methods of modulating short-chain dehydrogenase activity
|
WO2015073913A1
(en)
|
2013-11-16 |
2015-05-21 |
Terumo Bct, Inc. |
Expanding cells in a bioreactor
|
WO2016114819A1
(en)
|
2015-01-16 |
2016-07-21 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
EP3094352B1
(de)
|
2014-01-16 |
2020-09-23 |
Academia Sinica |
Zusammensetzungen und verfahren zur behandlung und zum nachweis von krebs
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US11008547B2
(en)
|
2014-03-25 |
2021-05-18 |
Terumo Bct, Inc. |
Passive replacement of media
|
TWI687428B
(zh)
|
2014-03-27 |
2020-03-11 |
中央研究院 |
反應性標記化合物及其用途
|
WO2015164228A1
(en)
|
2014-04-21 |
2015-10-29 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
SG10201809290SA
(en)
|
2014-04-25 |
2019-01-30 |
Childrens Medical Ct Corp |
Compositions and Methods to Treating Hemoglobinopathies
|
US11918695B2
(en)
|
2014-05-09 |
2024-03-05 |
Yale University |
Topical formulation of hyperbranched polymer-coated particles
|
EP3139909A4
(de)
|
2014-05-09 |
2018-01-03 |
Yale University |
Topische formulierung von hyperverzweigten polyglycerolbeschichteten partikeln
|
AU2015267045B2
(en)
|
2014-05-27 |
2021-02-25 |
Academia Sinica |
Anti-HER2 glycoantibodies and uses thereof
|
AU2015267052A1
(en)
|
2014-05-27 |
2016-12-15 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
KR20220151036A
(ko)
|
2014-05-27 |
2022-11-11 |
아카데미아 시니카 |
항-cd20 글리코항체 및 이의 용도
|
US11332523B2
(en)
|
2014-05-28 |
2022-05-17 |
Academia Sinica |
Anti-TNF-alpha glycoantibodies and uses thereof
|
WO2016011381A1
(en)
*
|
2014-07-18 |
2016-01-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Reducing cxcr4 expression and/or function to enhance engraftment of hematopoietic stem cells
|
EP3473271B1
(de)
|
2014-07-31 |
2022-07-20 |
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services |
Humane monoklonale antikörper gegen epha4 und deren verwendung
|
CN107001404B
(zh)
|
2014-09-08 |
2021-06-29 |
中央研究院 |
使用醣脂激活人类iNKT细胞
|
EP3191526B1
(de)
|
2014-09-12 |
2023-02-22 |
The Board of Trustees of the Leland Stanford Junior University |
Agonistenmoleküle des wnt-signalwegs
|
US20160090569A1
(en)
|
2014-09-26 |
2016-03-31 |
Terumo Bct, Inc. |
Scheduled Feed
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
KR20170104617A
(ko)
|
2015-01-24 |
2017-09-15 |
아카데미아 시니카 |
신규한 글리칸 콘주게이트 및 이를 사용하는 방법
|
EP3250682A4
(de)
|
2015-01-26 |
2018-08-01 |
Fate Therapeutics, Inc. |
Zellen mit erhöhten immunregulatorischen eigenschaften und verfahren zu deren verwendung und herstellung
|
US11572543B2
(en)
|
2015-05-08 |
2023-02-07 |
The Children's Medical Center. Corporation |
Targeting BCL11A enhancer functional regions for fetal hemoglobin reinduction
|
ES2889906T3
(es)
|
2015-05-21 |
2022-01-14 |
Harpoon Therapeutics Inc |
Proteínas de unión triespecíficas y usos médicos
|
WO2017004592A1
(en)
|
2015-07-02 |
2017-01-05 |
Terumo Bct, Inc. |
Cell growth with mechanical stimuli
|
EP4202036A1
(de)
|
2015-07-20 |
2023-06-28 |
Angiocrine Bioscience, Inc. |
Verfahren und zusammensetzungen zur stammzelltransplantation
|
AU2016296741A1
(en)
|
2015-07-21 |
2018-02-22 |
The Children's Medical Center Corporation |
PD-L1 expressing hematopoietic stem cells and uses
|
US11312940B2
(en)
|
2015-08-31 |
2022-04-26 |
University Of Louisville Research Foundation, Inc. |
Progenitor cells and methods for preparing and using the same
|
WO2017041027A1
(en)
|
2015-09-04 |
2017-03-09 |
Obi Pharma, Inc. |
Glycan arrays and method of use
|
US11207393B2
(en)
|
2015-10-16 |
2021-12-28 |
President And Fellows Of Harvard College |
Regulatory T cell PD-1 modulation for regulating T cell effector immune responses
|
RU2021103425A
(ru)
|
2016-02-12 |
2021-02-25 |
Блубёрд Био, Инк. |
Композиции, повышающие число копий вектора (чкв), и способы их применения
|
CN108883136A
(zh)
|
2016-02-12 |
2018-11-23 |
蓝鸟生物公司 |
Vcn增强子组合物及其使用方法
|
CA3014795A1
(en)
|
2016-02-16 |
2017-08-24 |
Yale University |
Compositions and methods for treatment of cystic fibrosis
|
EP3416976A2
(de)
|
2016-02-16 |
2018-12-26 |
Yale University |
Zusammensetzungen zur verbesserung von gezielter geneditierung und verfahren zur verwendung davon
|
WO2017147212A1
(en)
|
2016-02-22 |
2017-08-31 |
The Regents Of The University Of California |
Compositions and methods for imaging cell populations
|
EP3423568A4
(de)
|
2016-03-04 |
2019-11-13 |
University Of Louisville Research Foundation, Inc. |
Verfahren und zusammensetzungen zur ex-vivo-vermehrung von sehr kleinen embryonalen stammzellen (vsels)
|
AU2017231749A1
(en)
|
2016-03-08 |
2018-09-20 |
Academia Sinica |
Methods for modular synthesis of N-glycans and arrays thereof
|
US20210309965A1
(en)
|
2016-03-21 |
2021-10-07 |
Dana-Farber Cancer Institute, Inc. |
T-cell exhaustion state-specific gene expression regulators and uses thereof
|
CN109311995A
(zh)
|
2016-03-29 |
2019-02-05 |
台湾浩鼎生技股份有限公司 |
抗体、药物组合物和方法
|
US20200299649A1
(en)
|
2016-03-29 |
2020-09-24 |
Smsbiotech, Inc. |
Compositions and methods for using small mobile stem cells
|
US10980894B2
(en)
|
2016-03-29 |
2021-04-20 |
Obi Pharma, Inc. |
Antibodies, pharmaceutical compositions and methods
|
KR20180128496A
(ko)
|
2016-04-22 |
2018-12-03 |
오비아이 파머 인코퍼레이티드 |
글로보 계열 항원을 통한 면역 활성화 또는 면역 조정에 의한 암 면역요법
|
WO2017196847A1
(en)
|
2016-05-10 |
2017-11-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Variable new antigen receptor (vnar) antibodies and antibody conjugates targeting tumor and viral antigens
|
US11623958B2
(en)
|
2016-05-20 |
2023-04-11 |
Harpoon Therapeutics, Inc. |
Single chain variable fragment CD3 binding proteins
|
EP3461261A4
(de)
|
2016-05-20 |
2019-12-04 |
Harpoon Therapeutics Inc. |
Cd3-bindende proteine mit einkettigem variablem fragment
|
MX2018014228A
(es)
|
2016-05-20 |
2019-08-12 |
Harpoon Therapeutics Inc |
Proteina de union de albumina sérica de dominio unico.
|
EP3464565A4
(de)
|
2016-05-25 |
2020-01-01 |
Terumo BCT, Inc. |
Zellexpansion
|
US11685883B2
(en)
|
2016-06-07 |
2023-06-27 |
Terumo Bct, Inc. |
Methods and systems for coating a cell growth surface
|
US11104874B2
(en)
|
2016-06-07 |
2021-08-31 |
Terumo Bct, Inc. |
Coating a bioreactor
|
WO2017214182A1
(en)
|
2016-06-07 |
2017-12-14 |
The United States Of America. As Represented By The Secretary, Department Of Health & Human Services |
Fully human antibody targeting pdi for cancer immunotherapy
|
US10450599B2
(en)
|
2016-07-05 |
2019-10-22 |
California Institute Of Technology |
Fractional initiator hybridization chain reaction
|
CN110072545A
(zh)
|
2016-07-27 |
2019-07-30 |
台湾浩鼎生技股份有限公司 |
免疫原性/治疗性聚糖组合物及其用途
|
JP7121724B2
(ja)
|
2016-07-29 |
2022-08-18 |
オービーアイ ファーマ,インコーポレイテッド |
ヒト抗体、医薬組成物及び方法
|
US11066479B2
(en)
|
2016-08-02 |
2021-07-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Monoclonal antibodies targeting glypican-2 (GPC2) and use thereof
|
CN109963868B
(zh)
|
2016-08-22 |
2023-11-14 |
醣基生医股份有限公司 |
抗体、结合片段及使用方法
|
CA3034617A1
(en)
|
2016-08-30 |
2018-03-08 |
California Institute Of Technology |
Immunohistochemistry via hybridization chain reaction
|
KR102606101B1
(ko)
|
2016-10-24 |
2023-11-27 |
유나이티드 쎄러퓨틱스 코포레이션 |
트레프로스티닐에 의한 msc 면역조절 특성의 향상
|
CA3044274A1
(en)
|
2016-11-21 |
2018-05-24 |
Obi Pharma, Inc. |
Conjugated biological molecules, pharmaceutical compositions and methods
|
EP3544997A4
(de)
|
2016-11-23 |
2020-07-01 |
Harpoon Therapeutics, Inc. |
Prostataspezifisches membranantigenbindendes proteine
|
CN110198737A
(zh)
|
2016-11-23 |
2019-09-03 |
哈普恩治疗公司 |
靶向psma的三特异性蛋白质及使用方法
|
WO2018102552A1
(en)
|
2016-11-30 |
2018-06-07 |
Case Western Reserve University |
Combinations of 15-pgdh inhibitors with corcosteroids and/or tnf inhibitors and uses thereof
|
US11236171B2
(en)
|
2016-12-21 |
2022-02-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human monoclonal antibodies specific for FLT3 and uses thereof
|
JP2020514323A
(ja)
|
2017-02-06 |
2020-05-21 |
ケース ウエスタン リザーブ ユニバーシティ |
短鎖デヒドロゲナーゼ活性を調節する組成物と方法
|
WO2018152325A1
(en)
|
2017-02-15 |
2018-08-23 |
Bluebird Bio, Inc. |
Donor repair templates multiplex genome editing
|
EP3589662A4
(de)
|
2017-02-28 |
2020-12-30 |
Harpoon Therapeutics, Inc. |
Induzierbares monovalentes antigenbindendes protein
|
US11261441B2
(en)
|
2017-03-29 |
2022-03-01 |
Bluebird Bio, Inc. |
Vectors and compositions for treating hemoglobinopathies
|
US11629332B2
(en)
|
2017-03-31 |
2023-04-18 |
Terumo Bct, Inc. |
Cell expansion
|
US11624046B2
(en)
|
2017-03-31 |
2023-04-11 |
Terumo Bct, Inc. |
Cell expansion
|
WO2018187493A1
(en)
|
2017-04-04 |
2018-10-11 |
Yale University |
Compositions and methods for in utero delivery
|
AU2018261637A1
(en)
|
2017-05-03 |
2019-12-12 |
Biomarin Pharmaceutical Inc. |
Improved lentiviruses for transduction of hematopoietic stem cells.
|
CN110891974B
(zh)
|
2017-05-12 |
2021-08-06 |
哈普恩治疗公司 |
间皮素结合蛋白质
|
KR20200026810A
(ko)
|
2017-05-12 |
2020-03-11 |
하푼 테라퓨틱스, 인크. |
Msln 표적화 삼중 특이적 단백질 및 사용 방법
|
EP3625256A1
(de)
|
2017-05-19 |
2020-03-25 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Humaner monoklonaler antikörper gegen tnfr2 zur krebsimmuntherapie
|
WO2018218135A1
(en)
|
2017-05-25 |
2018-11-29 |
The Children's Medical Center Corporation |
Bcl11a guide delivery
|
WO2018226336A1
(en)
|
2017-06-09 |
2018-12-13 |
Providence Health & Services - Oregon |
Utilization of cd39 and cd103 for identification of human tumor reactive cells for treatment of cancer
|
WO2019005208A1
(en)
|
2017-06-30 |
2019-01-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
ANTIBODIES TO HUMAN MESOTHELIN AND USES IN ANTICANCER THERAPY
|
WO2019006280A1
(en)
|
2017-06-30 |
2019-01-03 |
Lentigen Technology, Inc. |
HUMAN MONOCLONAL ANTIBODIES SPECIFIC TO CD33 AND METHODS OF USE
|
US11879137B2
(en)
|
2017-09-22 |
2024-01-23 |
The Children's Medical Center Corporation |
Treatment of type 1 diabetes and autoimmune diseases or disorders
|
AU2018346955A1
(en)
|
2017-10-13 |
2020-04-30 |
Harpoon Therapeutics, Inc. |
B cell maturation antigen binding proteins
|
WO2019075359A1
(en)
|
2017-10-13 |
2019-04-18 |
Harpoon Therapeutics, Inc. |
TRISPECIFIC PROTEINS AND METHODS OF USE
|
WO2020006273A1
(en)
|
2018-06-27 |
2020-01-02 |
Juvena Therapeutics, Inc. |
Heparin-associated polypeptides and uses thereof
|
TW202035444A
(zh)
|
2018-06-27 |
2020-10-01 |
台灣浩鼎生技股份有限公司 |
用於糖蛋白工程的糖苷合成酶變體及其使用方法
|
JP7459043B2
(ja)
|
2018-07-12 |
2024-04-01 |
ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
親和性成熟cd22特異的モノクローナル抗体およびその使用
|
CN112585163A
(zh)
|
2018-08-08 |
2021-03-30 |
美国政府(由卫生和人类服务部的部长所代表) |
靶向磷脂酰肌醇蛋白聚糖-2的高亲和力单克隆抗体及其用途
|
BR112021003823A2
(pt)
|
2018-08-31 |
2021-05-25 |
Yale University |
composição, composição farmacêutica e método para modificar o genoma de uma célula
|
AU2019331009A1
(en)
|
2018-08-31 |
2021-03-18 |
Yale University |
Compositions and methods for enhancing donor oligonucleotide-based gene editing
|
IL281683B2
(en)
|
2018-09-25 |
2023-04-01 |
Harpoon Therapeutics Inc |
dll3 binding proteins and methods of use
|
CN113194992A
(zh)
|
2018-10-02 |
2021-07-30 |
伊米若梅有限公司 |
靶向epn1的抗体
|
US20210340562A1
(en)
|
2018-10-19 |
2021-11-04 |
Board Of Regents, The University Of Texas System |
Engineered long interspersed element (line) transposons and methods of use
|
EA202191422A1
(ru)
|
2018-11-21 |
2021-10-21 |
Кейс Вестерн Ризерв Юниверсити |
Композиции и способы модулирования активности короткоцепочечной дегидрогеназы
|
WO2020113025A1
(en)
|
2018-11-28 |
2020-06-04 |
Milica Radisic |
Methods for tissue generation
|
WO2020112195A1
(en)
|
2018-11-30 |
2020-06-04 |
Yale University |
Compositions, technologies and methods of using plerixafor to enhance gene editing
|
EP3883608A1
(de)
|
2019-01-08 |
2021-09-29 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Speziesübergreifende einzeldomänenantikörper gegen mesothelin zur behandlung von soliden tumoren
|
CN113784987A
(zh)
|
2019-01-22 |
2021-12-10 |
美国政府(由卫生和人类服务部的部长所代表) |
靶向磷脂酰肌醇蛋白聚糖-1的高亲和力单克隆抗体和使用方法
|
CA3140430A1
(en)
|
2019-05-14 |
2020-11-19 |
Harpoon Therapeutics, Inc. |
Epcam binding proteins and methods of use
|
EP3983545A1
(de)
|
2019-06-17 |
2022-04-20 |
Vertex Pharmaceuticals Incorporated |
Zusammensetzungen und verfahren zum editieren von beta-globin zur behandlung von hämaglobinopathien
|
US20220372474A1
(en)
|
2019-06-21 |
2022-11-24 |
Yale University |
Hydroxymethyl-modified gamma-pna compositions and methods of use thereof
|
US20220243211A1
(en)
|
2019-06-21 |
2022-08-04 |
Yale University |
Peptide nucleic acid compositions with modified hoogsteen binding segments and methods of use thereof
|
WO2021022161A1
(en)
|
2019-07-31 |
2021-02-04 |
Yale University |
Compositions and methods for treating sickle cell disease
|
KR20220101073A
(ko)
|
2019-08-30 |
2022-07-19 |
예일 유니버시티 |
핵산을 세포로 전달하기 위한 조성물 및 방법
|
AU2020370125A1
(en)
|
2019-10-22 |
2022-05-19 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
High affinity nanobodies targeting B7H3 (CD276) for treating multiple solid tumors
|
CN115768463A
(zh)
|
2020-02-21 |
2023-03-07 |
哈普恩治疗公司 |
Flt3结合蛋白及使用方法
|
AU2021275122A1
(en)
|
2020-05-20 |
2022-12-15 |
Board Of Regents Of The University Of Texas System |
Compositions and methods of modulating short-chain dehydrogenase activity
|
US20230265214A1
(en)
|
2020-08-31 |
2023-08-24 |
Yale University |
Compositions and methods for delivery of nucleic acids to cells
|
WO2022093745A1
(en)
|
2020-10-26 |
2022-05-05 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Single domain antibodies targeting sars coronavirus spike protein and uses thereof
|
US20220228142A1
(en)
|
2020-12-17 |
2022-07-21 |
Vertex Pharmaceuticals Incorporated |
Compositions and methods for editing beta-globin for treatment of hemaglobinopathies
|
EP4284925A1
(de)
|
2021-01-26 |
2023-12-06 |
California Institute of Technology |
Allosterische bedingte guide-rnas zur zellselektiven regulierung von crispr/cas
|
WO2022216942A1
(en)
|
2021-04-07 |
2022-10-13 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for the treatment of cancer
|
WO2022232612A1
(en)
|
2021-04-29 |
2022-11-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Lassa virus-specific nanobodies and methods of their use
|
WO2022261115A1
(en)
|
2021-06-07 |
2022-12-15 |
Yale University |
Peptide nucleic acids for spatiotemporal control of crispr-cas binding
|
BR112023022097A2
(pt)
|
2021-06-07 |
2023-12-19 |
Agonox Inc |
Cxcr5, pd-1 e icos expressando células t cd4 reativas de tumor e seu uso
|
CA3216228A1
(en)
|
2021-06-09 |
2022-12-15 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cross species single domain antibodies targeting pd-l1 for treating solid tumors
|
AU2022345251A1
(en)
|
2021-09-17 |
2024-03-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Synthetic humanized llama nanobody library and use thereof to identify sars-cov-2 neutralizing antibodies
|
WO2023076881A1
(en)
|
2021-10-26 |
2023-05-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Single domain antibodies targeting the s2 subunit of sars-cov-2 spike protein
|
WO2023086969A2
(en)
|
2021-11-12 |
2023-05-19 |
Ichor Medical Systems Inc. |
Treatment methods
|
WO2024020597A1
(en)
|
2022-07-22 |
2024-01-25 |
The Johns Hopkins University |
Dendrimer-enabled targeted intracellular crispr/cas system delivery and gene editing
|
WO2024050399A1
(en)
|
2022-09-01 |
2024-03-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Single domain antibodies targeting hpv e6/e7 oncogenic peptide/mhc complexes
|
WO2024081736A2
(en)
|
2022-10-11 |
2024-04-18 |
Yale University |
Compositions and methods of using cell-penetrating antibodies
|